Inpatient burden and association with comorbidities of polyarteritis nodosa: National Inpatient Sample 2014.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 04 2019
revised: 19 07 2019
accepted: 22 07 2019
pubmed: 1 8 2019
medline: 5 2 2021
entrez: 1 8 2019
Statut: ppublish

Résumé

To characterize inpatient burden, expenditures and association with comorbidities of polyarteritis nodosa (PAN). Patients with PAN were identified from the Nationwide Inpatient Sample (NIS) database for the year 2014 using ICD-9 diagnostic codes. The primary outcome was determining the inpatient prevalence of PAN in hospitalized patients in the US. Secondary outcomes included determining inpatient mortality, morbidity, comorbidities, hospital length of stay (LOS) and total hospital costs and charges. A cohort of patients without PAN was also identified from the same database to serve as comparators for analysis of comorbidities. Multivariate regression analysis was used to adjust for age, gender, ethnicity, comorbidities and hospital characteristics. A total of 4,110 patients with PAN were included in the study. The mean age was 59.5 years and 61% were female. The inpatient prevalence of PAN was 11.6 cases per 100,000 discharges. Patients with PAN displayed increased adjusted odds of mortality (OR:1.35, p = 0.13), shock (OR:1.75, p<0.01), ICU admission (OR:1.88, p<0.01) and multiorgan failure (OR:3.12, p<0.01) compared to patients without PAN. Patients with PAN also displayed significantly higher hospital costs (additional adjusted mean [aAM]: $9,693, p<0.01), hospitalization charges (aAM: $34,273, p<0.01) and LOS (aAM: 4.1 days, p<0.01) compared to patients without PAN. Analysis of comorbidities found a significant association between PAN and venous thromboembolism, renal injury and sepsis. The main limitation of this study was reliance on accuracy of diagnostic coding. The high inpatient prevalence of PAN might have been inflated and we cannot be certain that the higher risk of comorbidities and expenditures were entirely attributable to PAN as some patients in this cohort may have other vasculitides. The inpatient prevalence of PAN is higher than what would be expected from the overall general prevalence. Hospitalizations of patients with PAN are associated with significantly higher rates of morbidity and expenditures.

Identifiants

pubmed: 31362895
pii: S0049-0172(19)30279-3
doi: 10.1016/j.semarthrit.2019.07.009
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-70

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have disclosed no conflict of interest.

Auteurs

Patompong Ungprasert (P)

Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, 3rd Floor SIMR Building, Mahidol University, Bangkok 10700, Thailand. Electronic address: p.ungprasert@gmail.com.

Matthew J Koster (MJ)

Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, United States.

Wisit Cheungpasitporn (W)

Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, United States.

Karn Wijarnpreecha (K)

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Jacksonville, FL, United States.

Charat Thongprayoon (C)

Division of Nephrology, Department of Medicine, Mayo Clinic, Rochester, MN, United States.

Paul T Kroner (PT)

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Jacksonville, FL, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH